Nanotechnology devices can detect the risk of serious complications during pregnancy

This condition is called placental hyperplasia spectrum disorder.

At present, the diagnosis of placental hyperplasia spectrum disease is assessed by ultrasound combined with the mother's pregnancy history

This new blood test can be performed as early as the first trimester of pregnancy, so that it can be referred to a doctor who specializes in high-risk pregnancies as soon as possible

Dr.

A paper detailing the new method was published in Nature Communications today

This new method uses a technology called NanoVelcro Chip (NanoVelcro Chip), which was developed by Dr.

In this new study, the researchers modified the chip to enable it to detect placental cells related to placental hyperplasia spectrum disorders in the mother's blood

"Seeing the trophoblast cell clusters for the first time is like seeing sparkling pearls," said Zhu, one of the study's senior authors

Dr.

Pisarska, the senior co-author of this study, said: "The efficacy of this test and the power of our work comes from bringing together experts from multiple disciplines, including obstetrics, nanotechnology, pathology, engineering, chemistry, microfluidics, and Biostatistics

Researchers are exploring ways to improve the test to improve its accuracy and reliability

Journal Reference :

1. Yalda Afshar, Jiantong Dong, Pan Zhao, Lei Li, Shan Wang, Ryan Y.